Patient-Reported Bowel Function and Bowel-Related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection

Authors

Michael K Rooney
Brian De
Kelsey Corrigan
Grace L Smith
Cullen Taniguchi
Bruce D Minsky
Ethan B Ludmir
Eugene J Koay
Prajnan Das
Albert C Koong
Oliver Peacock
George Chang
Y Nancy You
Van K Morris
Graciela Nogueras-González
Emma B Holliday

Publication Date

6-1-2023

Journal

Clinical Colorectal Cancer and Other Gastrointestinal Malignancies

Abstract

INTRODUCTION: Multimodality treatment for locally advanced rectal cancer (LARC) can include long-course radiotherapy (LCRT) or short course radiotherapy (SCRT). Nonoperative management is increasingly pursued for those achieving a complete clinical response. Data regarding long-term function and quality-of-life (QOL) are limited.

METHODS: Patients with LARC treated with radiotherapy from 2016 to 2020 completed the Functional Assessment of Cancer Therapy- General (FACT-G7), the Low Anterior Resection Syndrome Score (LARS) and the Fecal Incontinence QOL Scale (FIQOL). Univariate and multivariable linear regression analyses identified associations between clinical variables including radiation fractionation and the use of surgery versus non-operative management.

RESULTS: Of 204 patients surveyed, 124 (60.8%) responded. Median (interquartile range) time from radiation to survey completion was 30.1 (18.3-43) months. Seventy-nine (63.7%) respondents received LCRT, and 45 (36.3%) received SCRT; 101 (81.5%) respondents underwent surgery, and 23 (18.5%) pursued nonoperative management. There were no differences in LARS, FIQoL or FACT-G7 between patients receiving LCRT versus SCRT. On multivariable analysis, only nonoperative management was associated with lower LARS score signifying less bowel dysfunction. Nonoperative management and female sex were associated with a higher FIQoL score signifying less disruption and distress from fecal incontinence issues. Finally, lower BMI at the time of radiation, female sex, and higher FIQoL score were associated with higher FACT-G7 scores signifying better overall QOL.

CONCLUSIONS: These results suggest long-term patient-reported bowel function and QOL may be similar for individuals receiving SCRT and LCRT for the treatment of LARC, but nonoperative management may lead to improved bowel function and QOL.

Keywords

Humans, Female, Rectal Neoplasms, Defecation, Fecal Incontinence, Quality of Life, Postoperative Complications, Neoadjuvant Therapy, Adenocarcinoma, Patient Reported Outcome Measures

Comments

Supplementary Materials

PMID: 36878805